As Cuba's public healthcare system faces one of its most challenging times, the government continues to tout the island as a "medical powerhouse" by unveiling a "world-exclusive" surgical procedure for treating Parkinson's Disease. This treatment can cost patients over $20,000.
The Cuban Medical Services Marketing Company has promoted the technique, known as selective dorsolateral subthalamotomy, as a "revolutionary and exclusive" option for those suffering from this neurodegenerative disorder. This announcement coincided with World Parkinson's Day on April 11, a day dedicated to raising awareness of the disease that affects millions globally.
High-Cost Treatment Beyond Reach
The surgical program, conducted at the International Center for Neurological Restoration (CIREN), is divided into two phases. The first phase involves a week-long medical evaluation costing $3,616, which includes clinical, neurological, neuropsychological, and electrophysiological tests. The second phase is the stereotactic functional surgery, followed by a 10 to 15-night postoperative stay. The surgical procedure itself ranges between $15,000 and $20,000, depending on the specific technique utilized. Additionally, a mandatory companion for the patient must pay $43 per day for lodging and meals in the same room.
Overall, the complete treatment package can exceed $25,000, a sum well beyond the reach of average Cuban citizens, whose monthly salaries are less than $20.
Healthcare Crisis vs. Medical Tourism
Despite claims by Cuban authorities that the treatment has shown high efficacy and tolerance in over 200 surgeries performed, the promotion of these international services starkly contrasts with the island's severe healthcare crisis.
In Cuban hospitals and clinics, there is a chronic shortage of medications, syringes, anesthetics, and basic materials. Emergency rooms lack essential conditions, forcing families to bring everything from bandages to food for admitted relatives.
Nevertheless, the regime continues to allocate resources and highly skilled personnel to the lucrative medical tourism industry, leaving millions of Cubans to deal with collapsing primary care services and deplorable hospital conditions.
More Propaganda than Accessibility
While the selective dorsolateral subthalamotomy is presented as a "world-unique" surgical advancement that sets Cuba apart, it is primarily available to wealthy foreigners or elites connected to the government. Thus, the so-called "medical powerhouse" fails to benefit its own citizens, instead serving as a commercial showcase aimed at foreign markets, while ordinary Cubans wait indefinitely for a doctor's appointment, medication, or an ambulance that never arrives.
Cuban Medical System and Parkinson's Treatment: Key Questions
What is selective dorsolateral subthalamotomy?
Selective dorsolateral subthalamotomy is a surgical procedure promoted by Cuba as an exclusive treatment for Parkinson's Disease, offering a novel approach to managing this neurodegenerative disorder.
How much does the Parkinson's treatment in Cuba cost?
The total cost of the treatment, including evaluation and surgery, can exceed $25,000. This is a significant amount, especially considering the average Cuban salary is under $20 per month.
Why is the Cuban healthcare system in crisis?
The Cuban healthcare system faces severe challenges, including shortages of medications and basic supplies, inadequate hospital conditions, and the allocation of resources to medical tourism rather than addressing domestic healthcare needs.